USING AI AND NEUROIMAGING
ADVANCED CLINICAL TRIALS AND THERAPIES
OPTIMIZED THERAPIES
OPTIMAL MEASURES
Qynapse is a medical technology company, spin-off of the CATI consortium of neuroimaging research laboratories.
Qynapse is a medical technology company, spin-off of the CATI consortium of neuroimaging research laboratories.
NEWS
https://www.qynapse.com/wp-content/uploads/2020/02/QyScore-FDA-approval_image6.png
450
1050
ysalledechou
https://www.qynapse.com/wp-content/uploads/2019/06/Qynapse_HD.png
ysalledechou2020-02-03 14:37:552020-02-03 15:14:34Qynapse receives FDA clearance for QyScore®, a novel imaging software for central nervous system diseases
https://www.qynapse.com/wp-content/uploads/2019/07/AAIC2019.png
450
1050
ddempure
https://www.qynapse.com/wp-content/uploads/2019/06/Qynapse_HD.png
ddempure2019-07-01 15:58:502019-08-14 10:15:57Qynapse exhibits at the 2019 Alzheimer’s Association International Conference (AAIC) in Los Angeles, CA
https://www.qynapse.com/wp-content/uploads/2019/07/QyScore.png
300
700
ddempure
https://www.qynapse.com/wp-content/uploads/2019/06/Qynapse_HD.png
ddempure2019-04-11 23:07:192019-08-14 12:08:06Qynapse releases new validation results of QyScore performance
https://www.qynapse.com/wp-content/uploads/2019/07/ADPD-1.png
450
1050
ddempure
https://www.qynapse.com/wp-content/uploads/2019/06/Qynapse_HD.png
ddempure2019-02-25 08:32:042019-08-19 14:21:05Qynapse attended the 14th AD/PD International Conference
Qynapse is a medical technology company that unlocks the potential of quantitative imaging and AI to optimize diagnosis, prognosis and longitudinal monitoring of patients with neurological diseases.
